96109 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom; Six-membered rings Pyridine rings
Sub-classes:REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS
#2IRON REPLACEMENT TREATMENTS
#3METHOD FOR PRODUCING IMIDIC ACID OR IMIDIC ACID SALT
#4SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOF
#5LIGAND-ASSISTED DEOXYGENATION OF PHOSPHATES TO FORM NITROGEN-CONTAINING PHOSPHORUS(V) PRECURSORS AND THEIR SUBSEQUENT CONVERSION TO VARIOUS OXYPHOSPHORUS COMPOUNDS
#6NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF
#7Heteroaryl compounds as inhibitors of TYK2/JAK1, composition and application thereof
#818F-LABELED PSMA-TARGETED PET IMAGING AGENTS
#9NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE IN CROP PROTECTION
#10SPLEEN TYROSINE KINASE INHIBITORS AND METHODS OF USE THEREOF
#11A NOVEL THIOL REDUCTANT, PREPARATION METHOD AND USE THEREOF
#12IRON-CATALYZED METATHESIS POLYMERIZATION OF OLEFINS
#13GPR40 AGONISTS
#14INHIBITORS OF MEK KINASE
#15SUBSTITUTED PYRIDINES AS DNMT1 INHIBITORS
#16METHOD FOR SYNTHESIZING 1H-FURO[3,2-B]IMIDAZO[4,5-D]PYRIDINE COMPOUND
#17HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE
#18CHIRAL SYNTHONS FOR THE SYNTHESIS OF CHIRAL PHOSPHOROTHIOATES
#19PYRIDOXAL-5-PHOSPHATE (P5P) ANALOGS
#20HYDROSILYLATION PROCESS CATALYSED BY A COBALT COMPLEX
#21Heteroaryl compounds as inhibitors of TYK2, composition and application thereof
#22SULFUR/PHOSPHORUS-CONTAINING ARYL COMPOUND AND APPLICATION THEREOF
#23N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant
#24AZABICYCLO[3.1.0]HEXANE COMPOUND
#25PRODRUGS OF AZO COMPOUNDS AND THEIR SALTS
#26Substituted pyridines as DNMT1 inhibitors
#27Method of Treating Cancer With Atpenin A5 Derviatives
#28PYRIDINE-2-AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#29PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING
#30HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#31QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION
#32Inhibitors of MEK kinase
#33MULTI-COORDINATE GOLD-PHOSPHINE COMPOUNDS AND METHOD OF USE
#34BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#35Compound, Aldehyde Dehydrogenase 2 Activating Agent, Pharmaceutical Composition, and Therapeutic and/or Prophylactic Drug
#36Inhibitors of MEK kinase
#37REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS
#38Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus
#39METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES
#40GPR40 AGONISTS
#41Lysophosphatidic acid derivative
#4218F-LABELED PSMA-TARGETED PET IMAGING AGENTS
#43METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS
#44Immunomodulator compounds
#45Substituted pyridines as DNMT1 inhibitors
#46A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS
#47Minimally-invasive continuous clinical monitoring of small molecules with analytical accuracy
#48GPR40 agonists
#49LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME
#50GPR40 AGONISTS
#51Pyridyloxy-carboxylate derivative and preparation method therefor, herbicidal composition, and use
#52Quinone methide analog signal amplification
#53TORSEMIDE PHOSPHATE PRODRUG, PREPARATION METHOD AND COMPOSITION THEREOF
#54Targeting Redox-Active Pyridinium Cations to Mitochondria to Inhibit Proliferation of Drug-Resistant Cancer Cells
#55Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same
#56BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
#57Biological buffers with wide buffering ranges
#58N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant
#59Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
#60Biological buffers with wide buffering ranges
#61Skeletal removal of bisphosphonates
#62PYRIDYL BENZOTHIOPHENES AS KINASE INHIBITORS
#63PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#64Immunomodulator compounds
#65Electrochromic element
#66PYRIDINONE AND PYRIMIDINONE PHOSPHATES AND BORONATES USEFUL AS ANTIBACTERIAL AGENTS
#67Fluoro-pyridinone phosphates and boronates useful as antibacterial agents
#68Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes
#69Prodrugs of pyridone amides useful as modulators of sodium channels
#70PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#71Electrochromic compound, electrochromic composition, and display element
#72PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#73Hydrogenation and dehydrogenation catalyst, and methods of making and using the same
#74Phosphonium-ion tethered tetracycline drugs for treatment of cancer
#75Biological buffers with wide buffering ranges
#76PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#77Imines with tunable nucleophilicity and steric properties through metal coordination: applications as ligands and metalloorganocatalysts
#78PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#79N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and use thereof
#80Kinase inhibitors
#81Imines with tunable nucleophilicity and steric properties through metal coordination: applications as ligands and metalloorganocatalysts
#82Prodrugs of pyridone amides useful as modulators of sodium channels
#83Propyl-bridged diphosphine ligands for alkoxycarbonylation
#84Skeletal removal of bisphosphonates
#85Quinone methide analog signal amplification
#86Quinone methide analog signal amplification
#87Charged linkers and their uses for conjugation
#88Charged linkers and their uses for conjugation
#89Charged linkers and their uses for conjugation
#90Methoxycarbonylation with formic acid as CO source
#91Electrochromic compound, electrochromic composition, and display element
#92Phosphine-based compound and organic electroluminescence device including the same
#93Organic electron transport material and organic electroluminescent element using same
#94BONE ACTIVE NITROGEN-CONTAINING BISPHOSPHONATES WITH A NEAR INFRARED FLUORESCENT LABEL
#95Electrochromic compounds with improved color stability in their radical states
#96BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#97Compounds for the treatment of addiction
#98Kinase inhibitors
#99Kinase inhibitors
#100Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#101Triphenylene-based materials for organic electroluminescent devices
#102Heterocyclic compound and organic light emitting diode comprising same
#103CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME
#104Process for making phosphoramidate protected nucleoside compounds
#105Pyridyl benzothiophenes as kinase inhibitors
#106Pyridyl benzothiophenes as kinase inhibitors
#107Electrochromic compound, electrochromic composition, electrochromic element, and electrochromic dimming element
#108Prodrugs of pyridone amides useful as modulators of sodium channels
#109Process for the alkoxycarbonylation of ethers
#110Immunomodulator compounds
#111Process for the preparation of acylphosphanes
#112Oxidized lipids and methods of use thereof
#113Substituted phosphoramidate compounds and uses thereof
#114Asymmetrical hydrogenation reaction of ketonic acid compound
#115Imines with tunable nucleophilicity and steric properties through metal coordination: applications as ligands and metalloorganocatalysts
#116Charged linkers and their uses for conjugation
#117Activators of glucokinase
#118Ferrocene-based compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#119Monophosphine compounds and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds
#120Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device
#121Prodrugs of pyridone amides useful as modulators of sodium channels
#122Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device
#123Phenicol antibacterials
#124Chemical Compounds
#125Sheet integrated rare earth complex and use thereof
#126Organic electronic device
#127Alkoxyamines for the treatment of cancers
#12818F-labeled PSMA-targeted PET imaging agents
#129Complex catalysts based on amino-phosphine ligands for hydrogenation and dehydrogenation processes
#130Linkers for conjugation of cell-binding molecules
#131Phenicol antibacterials
#132Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
#133NOVEL UREA AND THIOUREA DERIVATIVES
#134Hydrogenation and dehydrogenation catalyst, and methods of making and using the same
#135Compounds as receptor modulators with therapeutic utility
#136Phenicol antibacterial agents
#137AMINOPYRIDINE COMPOUNDS AND THEIR USES
#138Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
#139Method and substances for preparation of N-substituted pyridinium compounds
#140Thionating agent
#141Synthesis of Drug Conjugates Via Reaction With Epoxide-Containing Linkers
#142Functionalized fluoroalkyl fluorophosphate salts
#143Pest control agent
#144Thionation process and a thionating agent
#145NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY
#146Nitroso compounds as nitroxyl donors and methods of use thereof
#147AZAPEPTIDE DERIVATIVES
#148Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity
#149THERAPEUTIC COMPOUNDS
#150Compounds for the treatment of addiction
#151Process for the carbonylation of ethylenically unsaturated compounds, novel carbonylation ligands and catalyst systems incorporating such ligands
#152Phospho-amino pincer-type ligands and catalytic metal complexes thereof
#153Exo- and diastereo-selective synthesis of himbacine analogs
#154Endosseous implant
#155PHOSPHINE OXIDE COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, PRODUCTION METHOD AND USES THEREOF
#156PHOSPHINE OXIDE COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, PRODUCTION METHOD AND USES THEREOF
#157Method for the manufacture of aminohydroxy diphosphonic acids
#158Oligonucleotide derivative comprising an aromatic compound
#159Squaric acid derivatives as inhibitors of the nicotinamide
#160Phosphorus containing compounds as protein kinase inhibitors
#161MATERIALS FOR ELECTRONIC DEVICES
#162METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE
#163High stability diionic liquid salts
#164PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME
#165Phosphorous derivatives as kinase inhibitors
#166Enzyme inhibiting compounds and methods
#167Copper complexes for optoelectronic applications
#168Compound and organic light-emitting diode, display and illuminating device using the compound
#169Azapeptide derivatives
#170Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1H)-one and derivatives thereof
#171Substituted pyrazolylamides useful as glucokinase activators
#172Rare-earth complex and uses thereof
#173Tricyclic compounds, compositions, and methods
#174PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#175Tricyclic compounds, compositions and methods
#176Compound and organic light-emitting diode, display and lighting device using the same
#177METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM
#178Gamma-amino-butyric acid derivatives as GABAreceptor ligands
#179Chemical compounds
#180Urea and thiourea derivatives
#181Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
#182Activators of glucokinase
#183Use of derivatives of (1-cyanocyclopropyl)phenylphosphinic acid, esters thereof and/or salts thereof for enhancing tolerance in plants to abiotic stress
#184ANTIVIRAL PHOSPHONATE ANALOGS
#185Organic electroluminescent device
#186AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY
#187Exo- and diastereo- selective synthesis of himbacine analogs
#188Method of ameliorating oxidative stress and supplementing the diet
#189METHOD FOR INTRODUCING FUNCTIONAL GROUP TO SURFACE OF MATERIAL
#190Compounds as receptor modulators with therapeutic utility
#191Macrocyclic Prodrug Compounds Useful as Therapeutics
#192Method for producing organic compound and organic compound obtained by the method
#193INHIBITORS OF p38
#194Compounds as receptor modulators with therapeutic utility
#195Substituted pyrazolylamide compounds useful as glucokinase activators
#196Phosphonium salts derivatives and uses thereof
#197Pyridyl inhibitors of hedgehog signalling
#198Insecticidal N-(heteroarylalkyl)alkanediamine derivatives
#199BISPHOSPHONATE-PROSTATIC ACID PHOSPHATASE INHIBITOR CONJUGATES TO TREAT PROSTATE CANCER BONE METASTASIS
#200Azapeptide derivatives
#201Electrochromic material and electrochromic device including the same
#202Process for the Preparation of Risedronate Sodium
#203Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#204Use of cyclovinyl phosphine/copper complexes as arylation catalysts
#205Optically compensated acrylic pressure-sensitive adhesive composition, polarizing plate and liquid crystal display device containing the same
#206Tricyclic compounds, compositions and methods
#207Hydrogenation of esters with Ru/bidentate ligands complexes
#208Gamma-amino-butyric acid derivatives as GABAreceptor ligands
#209HIV Protease Inhibiting Compounds
#210S1P3 receptor inhibitors for treating pain
#211METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS
#212N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE
#213METHOD FOR HYDROFORMYLATION
#214Endosseous implant
#215Pyridinecarboxamides as CXCR2 modulators
#216Protease inhibitors
#217PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE PHOSPHOROUS COMPOUND
#218Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate
#219HYDROGENATION OF ESTERS WITH RU/BIDENTATE LIGANDS COMPLEXES
#220Novel Process For Preparing Risedronic Acid
#221COMPOUND, PHOTOELECTRIC CONVERSION DEVICE AND PHOTOELECTROCHEMICAL BATTERY
#222Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction
#223Novel Phosphorus-Containing Thyromimetics
#224NOVEL CHAIN-BREAKING ANTIOXIDANTS
#225Chelating agents and highly luminescent and stable chelates and their use
#226Process for preparing sodium risedronate hemipentahydrate
#227CHEMICAL COMPOUNDS
#228Process for the Preparation of Biphosphonic Acids and Salts Thereof
#229Method for asymmetric synthesis
#230Inhibitors of p38
#231Process for producing biphosphonic acids and forms thereof
#232Exo- and diastereo-selective syntheses of himbacine analogs
#233Process for the preparation of [1-hydroxy-2-(3-pyridinyl)ethylidene] bisphosphonic acid and hemipentahydrate monosodium salt thereof
#234Tricyclic compounds, compositions and methods
#235PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#236Nitroso compounds as nitroxyl donors and methods of use thereof
#237Antiviral phosphonate analogs
#238Therapeutic compounds
#239ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS
#240Bone targeted therapeutics and methods of making and using the same
#241Novel Process For Making Bisphosphonic Acids Using Diluents Other Than Halogenated Hydrocarbons
#242N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#243Tetraphosphorus ligands for catalytic hydroformylation and related reactions
#244NOVEL PROCESS
#245Vinyl phosphonate lysophosphatidic acid receptor antagonists
#246Process for the preparation of pure risedronic acid or salts
#247KINASE INHIBITORY PHOSPHONATE ANALOGS
#248HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM
#249Compositions and methods for modulating a kinase cascade
#250PHARMACEUTICALLY ACCEPTABLE SALTS AND HYDRATES OF RISEDRONIC ACID
#251OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM
#252PROCESS FOR MANUFACTURING BISPHOSPHONIC ACIDS
#253Phosphorus-containing thyromimetics
#254STABLE VITAMIN B6 DERIVATIVE
#255Transition metal phosphine complex, method for producing same, and anticancer agent containing transition metal phospine complex
#256DEUTERIUM-ENRICHED RISEDRONATE
#257Azapeptide derivatives
#258Sphingosine-1-phosphate receptor agonist and antagonist compounds
#259Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers
#260Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
#261Lysophosphatidic acid receptor selective antagonists
#262Synthesis of drug conjugates via reaction with epoxide-containing linkers
#263Tricyclic compounds, compositions, and methods
#264N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#265Process for Preparing a Pure Polymorphic Form of 3-Pyridyl-1-Hydroxyethylidine-1, 1-Bisphosphonic Acid Sodium Salt
#266Therapeutic compounds
#267Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
#268ORGANIC ELECTROLUMINESCENT DEVICE
#269PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES
#270Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#271Alpha-HYDROXY, alpha-SUBSTITUTED METHYLENEBISPHOSPHONATES AND PHOSPHONOACETATES
#272Process of Making Geminal Bisphosphonic Acids and Pharmaceutically Acceptable Salts and/or Hydrates Thereof
#273Method for enantioselective synthesis of phosphorus-stereogenic phosphines
#274Tricyclic compound, compositions, and methods
#275Chelating agents and highly luminescent and stable chelates and their use
#276ANTI-INFECTIVE PHOSPHONATE ANALOGS
#2772 (SULFONYL)ETHYL N,N,N',N' tetrakis(2 chloroethyl)phosphorodia
#278Sphingosine-1-phosphate (SIP) receptor agonists
#279Hydrogenation of esters with Ru/bidentate ligands complexes
#280Sulfonylethyl phosphorodiamidates
#281High stability diionic liquid salts
#282Therapeutic compounds
#283THERAPEUTIC COMPOUNDS
#284Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#285Phosphonate and phosphinate pyrazolylamide glucokinase activators
#286Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate
#287Inhibitors of β-lactamase
#288Therapeutic compounds
#289Bisphosphonate compounds and methods
#290Phosphinic acid derivatives
#291Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#292Tetraphosphorus ligands for catalytic hydroformylation and related reactions
#293Phosphonium salts derivatives
#294Method and compositions for identifying anti-hiv therapeutic compounds
#295Process for the preparation of biphosphonic acids
#296Process for the preparation of risedronate sodium hemi-pentahydrate
#297Potassium channel modulators
#298N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
#299Stable vitamin B6 derivative
#300Process for preparing bisphosphonic acids